Levi & Korsinsky announces that a class action lawsuit has been commenced in the United States District Court for the Southern District of New York on behalf of investors who purchased China Sky One Medical, Inc. (“China Sky One” or the “Company”) (Nasdaq: CSKI) stock between April 16, 2009 and February 14, 2012 (the “Class Period”).
For more information, click here: http://www.zlk.com/china-sky-one-medical-cski. There is no cost or obligation to you.
The Complaint alleges that defendants misrepresented and/or failed to disclose that China Sky One’s earnings and gross margins were inflated, and that the Company lacked adequate internal and financial controls. On May 19, 2011, China Economic Review published an article warning that China Sky One’s financial results were suspect, based on a comparison of the Company and its competitors.
On February 15, 2012, the Company announced that its Chief Executive Officer was being treated for a life threatening illness and was taking a medical leave of absence, and that 26 middle-management level employees, including nine from the accounting department, had resigned. As a result of the foregoing disclosures, the price of China Sky One common stock fell approximately 28%, from $1.53 per share on February 14, 2012 to close at $1.10 per share on February 15, 2012.If you suffered a loss in China Sky One you have until April 24, 2012 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn't require that you serve as a lead plaintiff. To obtain additional information, contact Joseph E. Levi, Esq. either via email at email@example.com or by telephone at (877) 363-5972, or visit http://www.zlk.com. Levi & Korsinsky has expertise in prosecuting investor securities litigation and extensive experience in actions involving financial fraud and represents investors throughout the nation, concentrating its practice in securities and shareholder litigation. Attorney advertising. Prior results do not guarantee similar outcomes.
Check Out Our Best Services for Investors
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Model portfolio
- Stocks trading below $10
- Intraday trade alerts